Related Experiment Video
Updated: Jun 24, 2026
04:24
Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
Smoking cessation interventions in COPD: a network meta-analysis of randomised trials
R Strassmann1, B Bausch, A Spaar
1Horten Centre for patient-oriented research and knowledge transfer, University of Zurich, Switzerland.
The European Respiratory Journal
|April 10, 2009
Summary
Smoking cessation counseling combined with nicotine replacement therapy is most effective for chronic obstructive pulmonary disease (COPD) patients. This combination significantly improves prolonged abstinence rates compared to other interventions.
Area of Science:
- Pulmonary Medicine
- Addiction Research
- Evidence-Based Medicine
Background:
- Chronic Obstructive Pulmonary Disease (COPD) is a major cause of morbidity and mortality worldwide.
- Smoking is the primary risk factor for COPD development and progression.
- Effective smoking cessation interventions are crucial for managing COPD patients.
Purpose of the Study:
- To rank the effectiveness of various smoking cessation interventions for COPD patients.
- To compare the efficacy of smoking cessation counseling (SCC) with or without pharmacotherapy or nicotine replacement therapy (NRT).
Main Methods:
- A systematic literature search was conducted across 10 databases.
- Randomized controlled trials (RCTs) of smoking cessation interventions were identified.
- A network meta-analysis using logistic regression was performed on data from 7,372 COPD patients.
Main Results:
- Smoking cessation counseling (SCC) combined with nicotine replacement therapy (NRT) demonstrated the highest effectiveness for prolonged abstinence (OR 5.08).
- SCC combined with an antidepressant was the second most effective intervention (OR 3.32).
- SCC alone showed borderline superiority over usual care (OR 1.81).
Conclusions:
- SCC combined with NRT is the most effective intervention for smoking cessation in COPD patients.
- Further research is needed to solidify these findings and optimize COPD treatment strategies.
- Comprehensive smoking cessation support is vital for improving outcomes in COPD management.
Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...